In June 2002, the Department of Health and Children in Ireland began a program to distribute tablets of potassium iodate to households as part of Irelands National Emergency Plan for Nuclear Accidents. Potassium iodate provides iodine, which when taken during a nuclear emergency, works by “topping off “ the thyroid gland to prevent the uptake of radioactive iodine that might be released into the environment by a nuclear accident. To test the potency of the tablets, a chemist dissolved one in 100.0 mL of water, made the solution acidic, and then added excess potassium iodide, which caused the following reaction to occur. IO 3 - +8I - +6H + → 3I 3 - +3H 2 O The resulting solution containing I 3 - was titrated with 0.0500 M Na 2 S 2 O 3 solution, using starch indicator to detect the end point. (In the presence of iodine, starch turns dark blue. When the S 2 O 3 2- has consumed all of the iodine, the solution becomes colorless.) The titration required 22.61 mL of the thiosulfate solution to reach the end point. The reaction during the titration was I 3 - +2S 2 O 3 2- → 3I - +S 4 O 6 2- How many milligrams of KIO 3 were in the tablet?
In June 2002, the Department of Health and Children in Ireland began a program to distribute tablets of potassium iodate to households as part of Irelands National Emergency Plan for Nuclear Accidents. Potassium iodate provides iodine, which when taken during a nuclear emergency, works by “topping off “ the thyroid gland to prevent the uptake of radioactive iodine that might be released into the environment by a nuclear accident. To test the potency of the tablets, a chemist dissolved one in 100.0 mL of water, made the solution acidic, and then added excess potassium iodide, which caused the following reaction to occur. IO 3 - +8I - +6H + → 3I 3 - +3H 2 O The resulting solution containing I 3 - was titrated with 0.0500 M Na 2 S 2 O 3 solution, using starch indicator to detect the end point. (In the presence of iodine, starch turns dark blue. When the S 2 O 3 2- has consumed all of the iodine, the solution becomes colorless.) The titration required 22.61 mL of the thiosulfate solution to reach the end point. The reaction during the titration was I 3 - +2S 2 O 3 2- → 3I - +S 4 O 6 2- How many milligrams of KIO 3 were in the tablet?
In June 2002, the Department of Health and Children in Ireland began a program to distribute tablets of potassium iodate to households as part of Irelands National
Emergency Plan for Nuclear Accidents. Potassium iodate provides iodine, which when taken during a nuclear emergency, works by “topping off “ the thyroid gland to prevent the uptake of radioactive iodine that might be released into the environment by a nuclear accident. To test the potency of the tablets, a chemist dissolved one in 100.0 mL of water, made the solution acidic, and then added excess potassium iodide, which caused the following reaction to occur.
IO
3
-
+8I
-
+6H
+
→
3I
3
-
+3H
2
O
The resulting solution containing
I
3
- was titrated with 0.0500 M
Na
2
S
2
O
3
solution, using starch indicator to
detect the end point. (In the presence of iodine, starch turns dark blue. When the
S
2
O
3
2-
has consumed all of the iodine, the solution becomes colorless.) The titration required 22.61 mL of the thiosulfate solution to reach the end point. The reaction during the titration was
The electrode balance potential is -0.118 V and the interface potential difference
is +5 mV. The overvoltage n will be 0.005 - (-0.118) = 0.123 V. Is it correct?
In the electrode Pt, H2(1 atm) | H+(a=1), if the electrode balance potential is -0.118 V and the interface potential difference is +5 mV. The current voltage will be 0.005 - (-0.118) = 0.123 V ¿Correcto?
In the electrode Pt, H2(1 atm) | H+(a=1) at 298K is 0.79 mA cm-2. If the balance potential of the electrode is -0.118 V and the potential difference of the interface is +5 mV. Determine its potential.
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, chemistry and related others by exploring similar questions and additional content below.
Author:Steven D. Gammon, Ebbing, Darrell Ebbing, Steven D., Darrell; Gammon, Darrell Ebbing; Steven D. Gammon, Darrell D.; Gammon, Ebbing; Steven D. Gammon; Darrell
Author:Steven D. Gammon, Ebbing, Darrell Ebbing, Steven D., Darrell; Gammon, Darrell Ebbing; Steven D. Gammon, Darrell D.; Gammon, Ebbing; Steven D. Gammon; Darrell